Trash today, ethanol tomorrow

University of Maryland research that started with bacteria from the Chesapeake Bay has led to a process that may be able to convert large volumes of all kinds of plant products, from leftover brewer’s mash to paper trash, into ethanol and other biofuel alternatives to gasoline.

That process, developed by University of Maryland professors Steve Hutcheson and Ron Weiner, is the foundation of their incubator company Zymetis, which was on view today in College Park for Maryland Governor Martin O’Malley and state and university officials.

Media highlights for February in Biophysical Journal

Bethesda, MD – A new and notable article entitled “Passage Times for Polymer Translocation Pulled through a Narrow Pore” appears in Volume 94, Issue 5, of the Biophysical Journal, which is available online.

“Passage Times for Polymer Translocation Pulled through a Narrow Pore”

Mayo Clinic proceedings highlights research about cardiovascular benefits of omega-3 fatty acids

Thousands of research studies have documented how the oils known as omega-3 fatty acids can benefit the cardiovascular system, particularly among people diagnosed with coronary artery disease. The incredible volume of research on this topic creates difficulty for many physicians and patients to stay current with findings and recommendations related to these oils.

Alarming growth in expected CO2 emissions in China, finds UC analysis

Berkeley - The growth in China's carbon dioxide (CO2) emissions is far outpacing previous estimates, making the goal of stabilizing atmospheric greenhouse gases even more difficult, according to a new analysis by economists at the University of California, Berkeley, and UC San Diego.

Injection of human umbilical cord blood helps the aging brain

When human umbilical cord blood cells (UCBC) were injected into aged laboratory animals, researchers at the University of South Florida (USF) found improvements in the microenvironment of the hippocampus region of the animals’ brains and a subsequent rejuvenation of neural stem/progenitor cells.

Advanced-stage ovarian cancer patients with BRCA live longer, may respond better to treatment

Tampa, Fla. - Two abstracts underscoring the importance of testing for BRCA1/2 mutations in women with ovarian cancer were presented at this week's Society of Gynecologic Oncologists 39th Annual Meeting on Women's Cancers, by researchers from The University of Texas M. D. Anderson Cancer Center.

Recurrent low-grade carcinoma of the ovary less responsive to chemo than more common ovarian cancers

Tampa, Fla.- Recurrent low-grade serous carcinoma, a rare type of ovarian cancer, is less sensitive to chemotherapy and therefore more difficult to treat than more common high-grade ovarian cancers, according to researchers from The University of Texas M. D. Anderson Cancer Center. The findings were reported at the Society of Gynecologic Oncologists 39th Annual Meeting on Women's Cancers.

Glaucoma associated with increased risk of cardiovascular death in black patients

Black patients with diagnosed and treated glaucoma and those with high pressure in their eyes appear to have an increased risk of death from cardiovascular causes, according to a report in the March issue of Archives of Ophthalmology, one of the JAMA/Archives journals.

Magnesium associated with lower risk for some strokes in male smokers

Male smokers who consume more magnesium appear to have a lower risk for cerebral infarction, a type of stroke that occurs when blood flow to the brain is blocked, according to a report in the March 10 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

Outlook improves for patients with non-Hodgkin lymphoma over past decade

Five- and 10-year survival rates for patients with non-Hodgkin lymphoma appear to have increased from the 1990s to the early 21st century, according to a report in the March 10 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

Non-Hodgkin lymphoma includes several cancers of the immune system that occur in approximately 20.4 of every 100,000 individuals, according to background information in the article. Treatment for the condition has evolved rapidly in recent years.